Ries, Carola H.
Roche Pharma AG (Germany)
3 papers on CoChatORCID 0000-0002-1855-8745
Most cited papers
- Verified
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell
Immune cells in cancerCancer Immunotherapy and Biomarkers
Cited by 1,384
- Verified
T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
Neubert, N. J., Schmittnaegel, M., Bordry, N., Nassiri, S., Wald, N., Martignier, C., Tillé, L., Homicsko, K., Damsky, W., Maby-El Hajjami, H., et al. (2018) · Science Translational Medicine
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 308
- Verified
Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
Baer, C., Squadrito, M. L., Laoui, D., Thompson, D., Hansen, S. K., Kiialainen, A., Hoves, S., Ries, C. H., Ooi, C.-H., & De Palma, M. (2016) · Nature Cell Biology
Immune cells in cancerCancer Immunotherapy and Biomarkers
Cited by 259
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free